Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 650 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Cancer Immunotherapies Don’t Work for Everyone: HLA Gene May Explain Why January 27, 2022 38% of Recurrent Breast Cancers Have a Different HER2 Status than... May 25, 2021 Penn State Researchers Working on Amazon Alexa Skill for Metastatic Breast... May 4, 2021 Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer June 7, 2019 Load more HOT NEWS ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis... Embryos in the Womb Can Get Gene Mutations That Lead to... Celebrating 10 years of partnership with ScottishPower and £35m raised What to Know About the Different Types of Mastectomies for Breast...
